ACTRN12608000135314
Completed
Not Applicable
A Multi-Center Feasibility Study Evaluating the Osprey Medical Contrast Removal System in participants with renal deficiency
Osprey Medical Pty Ltd0 sites40 target enrollmentMarch 14, 2008
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Contrast-induced nephropathy
- Sponsor
- Osprey Medical Pty Ltd
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The subject is at least 18 years of age, is a candidate for diagnostic or interventional percutaneous coronary procedure utilizing contrast has documented CKD and an estimated GFR is \<60 and \> 15 ml/min/1\.73 m2 , the subject (or subject’s legal representative) is willing and able to provide appropriate informed consent, the subject is willing and able to comply with the requirements of the study protocol, including the predefined follow\-up evaluations
Exclusion Criteria
- •Subject is know to be or suspected to be pregnant, has a life expectancy of less than twelve (12\) months, is allergic to contrast media nickel and/or titanium, has a known bleeding disorder (e.g., bleeding \-including thrombocytopenia \[\< 100,000 platelet count], heparin\-induced thrombocytopenia, hemophilia, or von Willebrand disease), is unavailable for follow\-up, has undergone percutaneous diagnostic or therapeutic procedure within 72 hours of the proposed contrast removal procedure, is currently participating in another investigational device or drug study, has a pacemaker lead or other device placed within the coronary sinus, has had a percutaneous mitral annuloplasty with the device placed in the coronary sinus, has diagnosis of NYHA Class IV heart failure or has had recent exacerbation of heart failure requiring hospitalization within last four weeks or baseline BNP of 900 or greater, has had an acute myocardial infarction within the last 72 hours, INR \> 1\.8 within one (1\) week of the procedure, has an active infection within the last month and/or WBC is \> 10\.0, has a Hb \< 10\.0 within one (1\) week of the procedure, is not an appropriate candidate for catheterization of the coronary arteries or coronary sinus, unstable clinical situation precluding placement or operation of the Osprey Medical Contrast Removal System coronary sinus catheter, the Principal Investigator determines the subject is not an appropriate candidate for the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A multi-national multicenter feasibility study of Integrated Care Networks in Parkinson disease: a patientcentered integrated care delivery model in Parkinson diseaseG20Parkinson diseaseDRKS00025764The Ottawa Hospital Research Institute/University of Ottawa and University of Ottawa Brain and Mind Research Institute32
Recruiting
Not Applicable
MesoCyto StudyJPRN-UMIN000038709Hyogo College of Medicine100
Terminated
Phase 2
Feasibility study of normoxic versus hyperoxic therapy after cardiac arrestCardiovascular - Other cardiovascular diseasesOut-of-hospital cardiac arrestACTRN12612001054808Medical Research Institute of New Zealand42
Completed
Phase 1
A multi-centered phase I study of feasibility in endoscopic hand suturing (EHS) of mucosal defects after gastric endoscopic submucosal dissectioearly gastric cancersJPRN-UMIN000033988ippon Medical School40
Recruiting
Not Applicable
Prospective, single-centre, feasibility study to evaluate the use of 18F-PSMA PET/CT in patients with biochemically active medullary thyroid cancer.Medullary thyroid cancerthyroid cancer10043739NL-OMON51749niversitair Medisch Centrum Groningen15